Table 5.
Summary of univariate and multivariate Cox regression analysis of overall survival duration in all non‐small cell lung carcinoma patients
| Characteristics | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P‐value | HR | 95% CI | P‐value | |
| Barx2 | ||||||
| Low | 1 | 1 | ||||
| High | 0.263 | 0.153–0.451 | <0.001* | 0.320 | 0.177–0.577 | <0.001* |
| Ki‐67 | ||||||
| Low | 1 | |||||
| High | 2.789 | 1.643–4.732 | <0.001* | |||
| Age(years) | ||||||
| ≤60 | 1 | |||||
| >60 | 0.680 | 0.408–1.135 | 0.140 | |||
| Sex | ||||||
| Male | 1 | |||||
| Female | 0.925 | 0.545–1.568 | 0.772 | |||
| Smoking habit | ||||||
| Never | 1 | |||||
| Ever | 0.822 | 0.492–1.375 | 0.456 | |||
| Histological type | ||||||
| Adenocarcinoma | 1 | |||||
| Squamous cell carcinoma | 1.041 | 0.598–1.813 | 0.886 | |||
| Others | 0.815 | 0.395–1.681 | 0.580 | |||
| Grade | ||||||
| Well | 1 | |||||
| Moderate to poor | 1.413 | 0.841–2.374 | 0.191 | |||
| T stage | ||||||
| T1 + T2 | 1 | |||||
| T3 | 1.104 | 0.267–4.562 | 0.892 | |||
| N stage | ||||||
| N0 | 1 | |||||
| N1 + N2 | 2.589 | 1.496–4.483 | 0.001* | |||
| TNM stage | ||||||
| I + II | 1 | |||||
| IIIA | 2.922 | 1.661–5.141 | <0.001* | |||
*
P < 0.05.
95% CI, 95% confidence interval; HR, hazard ratio, Barx2, BarH‐like homeobox 2.